Claims for Patent: 5,616,566

Summary for Patent: 5,616,566

Title:	Method of inhibiting HIV replication with 2',3'-dideoxyadenosine
Abstract:	A method for inhibiting intracellular replication of HIV in an HIV-infected individual comprising contacting the HIV reverse transcriptase in the HIV-infected cells with 2',3'-dideoxyadenosine-5'-triphosphate whose source is 2',3'-dideoxyadenosine or a pharmaceutically acceptable salt or prodrug thereof.
Inventor(s):	Mitsuya; Hiroaki (Rockville, MD), Broder; Samuel (Bethesda, MD), Yarchoan; Robert (Bethesda, MD)
Assignee:	The United States of America as represented by the Department of Health (Washington, DC)
Application Number:	08/056,043
Patent Claims:	1. A method for inhibiting HIV replication within an HIV-infected cell comprising contacting the HIV reverse transcriptase within that cell with 2',3'-dideoxyadenosine-5'-triphosphate. 2. A method for the intracellular inhibition of HIV replication in an HIV-infected individual comprising contacting the HIV reverse transcriptase in the HIV-infected cells of that individual with 2',3'-dideoxyadenosine-5'-triphosphate. 3. The method of claim 2, wherein the source of the 2',3'-dideoxyadenosine-5'-triphosphate is 2',3'-dideoxyadenosine or a pharmaceutically acceptable salt or prodrug ester thereof which is administered in a therapeutically effective amount to the individual. 4. A method for inhibiting HIV replication within an HIV-infected cell comprising treating said cells with 2',3'-dideoxyadenosine or a pharmaceutically acceptable salt thereof, wherein the resulting 2',3'-dideoxyadenosine-5'-triphosphate contacts the intracellular HIV reverse transcriptase.